Close×

CHEP Australia is working with social enterprise and environmental group The Nature Conservancy (TNC) to recycle oyster, mussel and scallop shells from wholesalers and restaurants in Geelong, Victoria.

The aim of the project is to use the shells to restore the degraded reefs in Melbourne’s Port Phillip Bay.

The reef structures were destroyed from dredge fishing during the 1800s and 1900s. The reefs accommodate oysters and mussels, which provide social and economic benefits such as preventing algal blooms by filtering runoff water and providing fish with habitats.

CHEP has provided reusable containers at the end of their useful economic life, along with sharing best practices in logistics and financial assistance to help reconnect the economy back to the natural ecology.

The containers enable the collection of discarded shellfish shells from food outlets and redirect them to a holding area provided by the City of Greater Geelong.

This process is performed by the team at Geelong Disabled Peoples Industries (GDPI). The shells are then cured over six months before being aggregated with limestone to form a ‘reef matrix’. The matrix is then submerged into a ‘hatchery’ along with oyster spawn, and then nature takes its course.

To date, 300 metres cubed of shells have been collected from participating food retailers, bypassing Geelong’s landfills to the shellfish restoration project.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.